Key result
AV valve replacement carries a ~31% prosthetic thrombosis risk, linked to younger age and pre-TCPC status.
Why the study?
Risk factors for developing prosthetic valve thrombosis after systemic atrioventricular valve replacement in patients with functional single ventricles remain poorly understood.
Cohort (n=28)
In pediatric patients with functional single ventricles, younger age, lower weight, and higher valve size-to-weight ratio are significant risk factors for prosthetic valve thrombosis after systemic atrioventricular valve replacement.
Answers are grounded in this paper and cite their sources.
PVT risk factors identified in single-ventricle patients; hypothesis-generating and requires prospective validation before practice change.
Risk factors for developing prosthetic valve thrombosis (PVT) after systemic atrioventricular valve replacement in patients with functional single ventricles remain poorly understood. Medical records of 39 operations in 28 patients with functional single ventricles who underwent systemic atrioventricular valve replacement between 1998 and 2021 were retrospectively reviewed. Clinical variables were compared between patients with and without PVT. Median age at operation was 20 (IQR: 10–57) months; body weight was 7.8 (4.9–11.4) kg. Valve size was 21 (19–22) mm, and ratio of valve size (mm) to weight (kg) was 2.4 (1.8–3.6). Valve replacement was performed before bidirectional Glenn procedure (BDG) in 8 cases, with BDG in 7 cases, between BDG and total cavopulmonary connection (TCPC) in 13 cases, with TCPC in 4 cases, and after TCPC in 7 cases. PVT occurred after 12 of 39 operations (31%). Significant differences existed in median age at operation (12 vs. 26 months, p = 0.003), median weight at operation (4.9 vs. 10.2 kg, p = 0.001), and median valve size/weight ratio (3.6 vs. 2.1, p = 0.002) between operations with and without PVT. PVT incidence was higher before TCPC completion: before BDG (4/8 operations, 50%), BDG (3/7, 43%), and between BDG and TCPC (5/13, 38%), compared to TCPC (0/4, 0%) and after TCPC (0/7, 0%) ( p < 0.001). Patients who developed PVT were younger and underweight; in these patients, the use of a relatively oversized prosthesis is clinically inevitable. Close monitoring for PVT is warranted, especially before TCPC completion.
No takes yet. Share an insight, caveat, or question.
Yamada et al. (2026) conducted a cohort in Functional single ventricle (n=28). Systemic atrioventricular valve replacement was evaluated on Prosthetic valve thrombosis (PVT). Prosthetic valve thrombosis occurred in 31% of operations and was associated with younger age, lower weight, higher valve size/weight ratio, and pre-TCPC status.
Synapse has enriched 10 related papers. Consider them for comparative context: